Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial

Autor: Lablanche, Sandrine, Vantyghem, Marie-Christine, Kessler, Laurence, Wojtusciszyn, Anne, Borot, Sophie, Thivolet, Charles, Girerd, Sophie, Bosco, Domenico, Bosson, Jean-Luc, Colin, Cyrille, Tetaz, Rachel, Logerot, Sophie, Kerr-Conte, Julie, Renard, Eric, Penfornis, Alfred, Morelon, Emmanuel, Buron, Fanny, Skaare, Kristina, Grguric, Gwen, Camillo-Brault, Coralie, Egelhofer, Harald, Benomar, Kanza, Badet, Lionel, Berney, Thierry, Pattou, François, Benhamou, Pierre-Yves, Malvezzi, Paolo, Tauveron, Igor, Roche, Béatrice, Noel, Christian, Frimat, Luc, Guerci, Bruno, Pernin, Nadine, Moisan, Anaick, Persoons, Virginie, Ezzouaoui, Rimed, Gmyr, Valery, Thony, Frédéric, Bricault, Yvan, Rodière, Mathieu, Sengel, Christian, Greget, Michel, Enescu, Iulian, Noel, Christian, Hazzan, Marc, Caiazzo, Robert, Torres, Fanelly, Le Mapihan, Kristel, Raverdy, Violetta, Pierredon, Marie-Ange, Valette, Pierre-Jean, Muller, Arnaud, Champagnac, Jean, Chaillous, Lucy, Dantal, Jacques, Cattan, Pierre, Riveline, Jean-Pierre, Moreau, François, Baltzinger, Philippe, Bahoune, Thibault
Zdroj: The Lancet Diabetes & Endocrinology; July 2018, Vol. 6 Issue: 7 p527-537, 11p
Abstrakt: Islet transplantation is indicated for patients with type 1 diabetes with severe hypoglycaemia or after kidney transplantation. We did a randomised trial to assess the efficacy and safety of islet transplantation compared with insulin therapy in these patients.
Databáze: Supplemental Index